"Opportunistic Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.
Descriptor ID |
D009894
|
MeSH Number(s) |
C01.539.597 C02.597 C03.684
|
Concept/Terms |
Opportunistic Infections- Opportunistic Infections
- Infection, Opportunistic
- Infections, Opportunistic
- Opportunistic Infection
|
Below are MeSH descriptors whose meaning is more general than "Opportunistic Infections".
Below are MeSH descriptors whose meaning is more specific than "Opportunistic Infections".
This graph shows the total number of publications written about "Opportunistic Infections" by people in this website by year, and whether "Opportunistic Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 1 | 0 | 1 |
2008 | 0 | 1 | 1 |
2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Opportunistic Infections" by people in Profiles.
-
Incidence of Nontuberculous Mycobacterial Pulmonary Infection, by Ethnic Group, Hawaii, USA, 2005-2019. Emerg Infect Dis. 2022 08; 28(8):1543-1550.
-
Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) study. Ann Rheum Dis. 2014 Nov; 73(11):1942-8.
-
The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy. Pharmacoepidemiol Drug Saf. 2011 Mar; 20(3):229-35.
-
Fears about HIV transmission in families with an HIV-infected parent: a qualitative analysis. Pediatrics. 2008 Nov; 122(5):e950-8.
-
Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med. 2005 Jul 28; 353(4):375-81.
-
A survival analysis of hospitalization among patients with acquired immunodeficiency syndrome. Am J Public Health. 1989 Dec; 79(12):1643-7.